Cited by 266Long-Term Effects of COVID-19COVID-19 Clinical Research StudiesSARS-CoV-2 and COVID-19 Research

Association of Self-reported COVID-19 Infection and SARS-CoV-2 Serology Test Results With Persistent Physical Symptoms Among French Adults During the COVID-19 Pandemic

Open access
Matta, Joane, Wiernik, Emmanuel, Robineau, Olivier, Carrat, Fabrice, Touvier, Mathilde, Severi, Gianluca, de Lamballerie, Xavier, Blanché, Hélène +76 more·2022·JAMA Internal Medicine

Abstract

Importance: After an infection by SARS-CoV-2, many patients present with persistent physical symptoms that may impair their quality of life. Beliefs regarding the causes of these symptoms may influence their perception and promote maladaptive health behaviors. Objective: To examine the associations of self-reported COVID-19 infection and SARS-CoV-2 serology test results with persistent physical symptoms (eg, fatigue, breathlessness, or impaired attention) in the general population during the COVID-19 pandemic. Design, Setting, and Participants: Participants in this cross-sectional analysis were 26 823 individuals from the French population-based CONSTANCES cohort, included between 2012 and 2019, who took part in the nested SAPRIS and SAPRIS-SERO surveys. Between May and November 2020, an enzyme-linked immunosorbent assay was used to detect anti-SARS-CoV-2 antibodies. Between December 2020 and January 2021, the participants reported whether they believed they had experienced COVID-19 infection and had physical symptoms during the previous 4 weeks that had persisted for at least 8 weeks. Participants who reported having an initial COVID-19 infection only after completing the serology test were excluded. Main Outcomes and Measures: Logistic regressions for each persistent symptom as the outcome were computed in models including both self-reported COVID-19 infection and serology test results and adjusting for age, sex, income, and educational level. Results: Of 35 852 volunteers invited to participate in the study, 26 823 (74.8%) with complete data were included in the present study (mean [SD] age, 49.4 [12.9] years; 13 731 women [51.2%]). Self-reported infection was positively associated with persistent physical symptoms, with odds ratios ranging from 1.39 (95% CI, 1.03-1.86) to 16.37 (95% CI, 10.21-26.24) except for hearing impairment (odds ratio, 1.45; 95% CI, 0.82-2.55) and sleep problems (odds ratio, 1.14; 95% CI, 0.89-1.46). A serology test result positive for SARS-COV-2 was positively associated only with persistent anosmia (odds ratio, 2.72; 95% CI, 1.66-4.46), even when restricting the analyses to participants who attributed their symptoms to COVID-19 infection. Further adjusting for self-rated health or depressive symptoms yielded similar results. There was no significant interaction between belief and serology test results. Conclusions and Relevance: The findings of this cross-sectional analysis of a large, population-based French cohort suggest that persistent physical symptoms after COVID-19 infection may be associated more with the belief in having been infected with SARS-CoV-2 than with having laboratory-confirmed COVID-19 infection. Further research in this area should consider underlying mechanisms that may not be specific to the SARS-CoV-2 virus. A medical evaluation of these patients may be needed to prevent symptoms due to another disease being erroneously attributed to "long COVID."

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1001/jamainternmed.2021.6454

Cites

22 of 22 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • Long COVID patients without confirmed diagnoses of acute SARS-CoV2 infection (defined by RT-PCR or serology test) were more likely to report symptomatic worsening, possibly suggesting increased nocebo effects in the population without biological proof.

    “In addition, long COVID patients without confirmed diagnoses of acute SARS-CoV2 infection (defined by RT-PCR or serology test) were more likely to report symptomatic worsening, possibly suggesting increased nocebo effects in the population without biological proof [28,39].”

    From Protective effect of COVID-19 vaccination against long COVID syndrome: A systematic review and meta-analysis (2023) · cites this paper as [39]

    Split into 2 atoms — 0 confirmed, 2 partially supported, 0 disputed, 0 misattributed, 0 unverifiable. Expand the claim to see per-atom verdicts.

    Experimental — accuracy not yet measured

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Cites

Flagged first, then by citations

1 of the 23 references couldn’t be matched to a known paper.

Cited by

Sorted by citations

Authors
Matta, J., Wiernik, E., Robineau, O., Carrat, F., Touvier, M., Severi, G., de Lamballerie, X., Blanché, H., Deleuze, J.-F., Gouraud, C., Hoertel, N., Ranque, B., Goldberg, M., Zins, M., Lemogne, C., Santé, P., Kab, S., Renuy, A., Le-Got, S., Ribet, C., Wiernik, E., Goldberg, M., Zins, M., Artaud, F., Gerbouin-Rérolle, P., Enguix, M., Laplanche, C., Gomes-Rima, R., Hoang, L., Correia, E., Barry, A. A., Senina, N., Severi, G., Allegre, J., Szabo de Edelenyi, F., Druesne-Pecollo, N., Esseddik, Y., Hercberg, S., Touvier, M., Charles, M.-A., Ancel, P.-Y., Benhammou, V., Ritmi, A., Marchand, L., Zaros, C., Lordmi, E., Candea, A., de Visme, S., Simeon, T., Thierry, X., Geay, B., Dufourg, M.-N., Milcent, K., Rahib, D., Lydie, N., Lusivika-Nzinga, C., Pannetier, G., Lapidus, N., Goderel, I., Dorival, C., Nicol, J., Carrat, F., Lai, C., Belhadji, L., Esperou, H., Couffin-Cadiergues, S., Gagliolo, J.-M., Blanché, H., Sébaoun, J.-M., Beaudoin, J.-C., Gressin, L., Morel, V., Ouili, O., Deleuze, J.-F., Ninove, L., Priet, S., Saba Villarroel, P. M., Fourié, T., Mohamed Ali, S., Amroun, A., Seston, M., Ayhan, N., Pastorino, B., & de Lamballerie, X.
Affiliations
  • Inserm (FR)
  • Assistance Publique – Hôpitaux de Paris (FR)
  • Université Paris Cité (FR)
  • for the Santé, Pratiques, Relations et Inégalités Sociales en Population Générale Pendant la Crise COVID-19–Sérologie (SAPRIS-SERO) Study Group
Corresponding author
Lemogne, Cédric
Venue
JAMA Internal Medicine
Published
2022-01-01
Volume
182
Issue
1
Pages
19
ISSN
2168-6106 (ISSN-L)
OpenAlex
W3213545755
Cited by
266
References
23
Citations by year
2026: 14 · 2025: 28 · 2024: 47 · 2023: 67 · 2022: 102 · 2021: 7 · 2014: 1
FWCI
26.67
Type
journal article
Language
en
Open access
Licence
other-oa
Locations
  • JAMA Internal Medicine (publishedVersion, other-oa)
  • PubMed Central (publishedVersion)
  • PubMed (publishedVersion)
  • HAL (submittedVersion, other-oa)
  • Florence Research (University of Florence) (submittedVersion)
  • LillOA (Université de Lille (University Of Lille)) (submittedVersion, other-oa)
Funders
  • AstraZeneca
  • L'Oreal USA
  • Agence Nationale de la Recherche (10-COHO-06, #ANR-20-COVI-000, ANR-20-COV5-0005, ANR-11-INBS-0002, ANR-10-COHO-0006, ANR-11-INBS, ANR-20-COVI-0009, ANR-10, #ANR-10-COHO-06)
  • Institut National de la Santé et de la Recherche Médicale (C20-26)
  • H. Lundbeck A/S
Topics
  • Health Sciences › Medicine › Neurology › Long-Term Effects of COVID-19
  • Health Sciences › Medicine › Infectious Diseases › COVID-19 Clinical Research Studies
  • Health Sciences › Medicine › Infectious Diseases › SARS-CoV-2 and COVID-19 Research
Keywords
COVID-19 pandemic, SARS-CoV-2, persistent physical symptoms, long COVID, self-reported infection, SARS-CoV-2 antibodies, serology testing, fatigue, dyspnea, sleep disorders, hearing loss, CONSTANCES cohort, French adults, health beliefs, quality of life
MeSH terms
COVID-19, COVID-19 Serological Testing, Adult, Cross-Sectional Studies, Female, France, Humans, Male, Middle Aged, Surveys and Questionnaires, Syndrome, Self Report

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review